Delirium is common after hematopoietic stem cell transplantation (HSCT) and is associated with increased morbidity and mortality. Early recognition and treatment have been shown to improve long-term outcomes. We sought to investigate the relationship between potential risk factors and the development of delirium following HSCT.
Methods
Fifty-four inpatients admitted for HSCT were assessed prospectively for delirium every 2 to 3 days during their inpatient stay using standardized delirium and neuropsychological measures. Self reports of medical history, medical records, and neurocognitive and psychiatric assessments were used to identify risk factors. Both pre- and post-HSCT risk factors were examined.
Results
Delirium incidence was 35% and occurred with highest frequency in the 2 weeks following transplant. The only pre-transplantation risk factor was lower oxygen saturation (P = .003). Post-transplantation risk factors for delirium included higher creatinine (P < .0001), higher blood urea nitrogen levels (P = .005), lower creatinine clearance (P = .0006), lower oxygen saturation (P = .001), lower hemoglobin (P = .04), and lower albumin (P = .03). There was no observed association with level of cognitive performance, transplant type, disease severity, medical comorbidity index, age, or conditioning regimen.
Conclusions
Routine laboratory values can assist in the identification of high-risk patients before delirium onset to improve early detection and treatment of delirium after HSCT.
FannJR.Neurological effects of psychopharmacological agents. Semin Clin Neuropsychiatry. 2002;7:196–205.
2.
GaudreauJD, GagnonP, HarelF, . Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol. 2005;23:6712–6718.
3.
MoritaT, TeiY, TsunodaJ, . Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage. 2001;22:997–1006.
4.
KosterS, HensensAG, SchuurmansMJ, . Consequences of delirium after cardiac operations. Ann Thorac Surg. 2012;93:705–711.
5.
WadaT, WadaM, WadaM, . Characteristics, interventions, and outcomes of misdiagnosed delirium in cancer patients. Palliat Support Care. 2010;8:125–131.
6.
BeglingerLJ, DuffK, van Der HeidenS, . Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients. Biol Blood Marrow Transplant. 2006;12:928–935.
7.
CentenoC, SanzA, BrueraE.Delirium in advanced cancer patients. Palliat Med. 2004;3:184–194.
8.
BrueraE, BushSH, WilleyJ, . Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer. 2009;115:2004–2012.
9.
CobbJ, GlantzMJ, NicholasPK, . Delirium in patients with cancer at the end of life. Cancer Pract. 2000;8:172–177.
10.
SiddiqiN, HouseAO, HolmesJD.Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35:350–364.
FannJR, AlfanoCM, Roth-RoemerS, . Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation. J Clin Oncol. 2007;25:1223–1231.
13.
OlofssonSM, WeitznerMA, ValentineAD, . A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer. 1996;4:351–357.
14.
LjubisavljevicV, KellyB.Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry. 2003;25:345–352.
15.
LawlorPG, GagnonB, ManciniIL, . Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000;160:786–794.
16.
GandreuJ, GagnonP, HarelF, . Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol. 2005;23:6712–6718.
FannJR, HubbardRA, AlfanoCM, . Pre- and post-transplantation risk factors for delirium onset and severity in patients undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2011;29:895–901.
19.
BeglingerLJ, DuffK, van Der HeidenS, . Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study. J Int Neuropsychol Soc. 2007;13:172–177.
20.
BeglingerLJ, MillsJA, VikSM, . The neuropsychological course of acute delirium in adult hematopoietic stem cell transplantation patients. Arch Clin Neuropsychol. 2011;26:98–109.
21.
SorrorML, MarisMB, StorbR, . Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–2919.
22.
SorrorML, GiraltS, SandmaierBM, . Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood. 2007;110:4606–4613.
23.
de BorjaMT, ChowE, BovettG, . The correlation among patients and health care professionals in assessing functional status using the karnofsky and eastern cooperative oncology group performance status scales. Support Cancer Ther. 2004;2:59–63.
24.
MaC, BandukwalaS, BurmanD, . Interconversion of three measures of performance status: an empirical analysis. Eur J Cancer. 2010;46:3175–3183.
TrzepaczPT, MittalD, TorresR, . Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001;13:229–242.
27.
BreitbartW, RosenfeldB, RothA, . The Memorial Delirium Assessment Scale. J Pain Symptom Manage. 1997;13:128–137.
28.
LawlorPG, FainsingerRL, BrueraED.Delirium at the end of life: critical issues in clinical practice and research. JAMA. 2000;284:2427–2429.
29.
CoxDR. Regression tables and life tables. Journal of the Royal Statistical Society SeriesB.1972;34:187–202.
30.
EfronB.The efficiency of Cox's likelihood function for censored data. Journal of the American Statistical Association. 1977;72:557–565.
31.
BenjaminiY, HochbergY.Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological).1995;57:289–300.
32.
FannJR.The epidemiology of delirium: a review of studies and methodological issues. Semin Clin Neuropsychiatry. 2000;5:64–74.
33.
PrietoJ, BlanchJ, AtalaJ, . Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20:1907–1917.
34.
KalisvaartKJ, de JongheJF, BogaardsMJ, . Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc. 2005;53:1658–1666.
35.
BjörkelundKB, HommelA, ThorngrenKG, . Reducing delirium in elderly patients with hip fracture: a multi-factorial intervention study. Acta Anaesthesiol Scand. 2010;54:678–688.
36.
InouyeSK, ZhangY, JonesRN, . Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med. 2007;167:1406–1413.
37.
BreitbartW, GibsonC, TremblayA.The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/ caregivers, and their nurses. Psychosomatics. 2002;43:183–194.
38.
SagawaR, AkechiT, OkuyamaT, . Etiologies of delirium and their relationship to reversibility and motor subtype in cancer patients. Jpn J Clin Oncol.2009; 39:175–182.
39.
ShiibaM, TakeiM, NakatsuruM, . Clinical observations of postoperative delirium after surgery for oral carcinoma. Int J Oral Maxillofac Surg. 2009; 38:661–665.
40.
MarcantonioER, GoldmanL, MangioneCM, . A clinical prediction rule for delirium after elective noncardiac surgery. JAMA. 1994;271:134–139.
41.
FannJR, AlfanoCM, BuringtonBE, . Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation. Cancer. 2005;103:810–820.
42.
MorrisonRS, MagazinerJ, GilbertM, . Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci.2003;58:76–81.
43.
RobinsonS, VollmerC.Undermedication for pain and precipitation of delirium. Medsurg Nurs. 2010;19:79–83.
44.
LarsenKA, KellySE, SternTA, . Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics. 2010;51:409–418.
